Substance Use Treatment Today Isn’t What You Think with Suzette Glasner, PhD

Substance use disorder is a growing issue in workplace healthcare, but it often remains hidden. Dr. Suzette Glasner, Clinical Psychologist and Chief Scientific Officer at Pelago, discusses the hidden impact of addiction in your claims data, how employers are taking action,  and what might surprise you about the latest research on effective addiction treatment. In this episode, you'll learn:The physical impact of addiction on employees and how this trickles down to healthcare costs Misconceptions about addiction treatment and Dr. Glasner’s thoughts on the headlines around psychedelics as addiction treatmentSurprising research Pelago led on the right “dose” of human support for recoveryHighlights:(00:00) Meet Dr. Suzette Glasner(02:07) The hype vs reality of psychedelic treatments for addiction(03:20) Why effective treatments are underutilized(07:13) The barriers of stigma, access, and insight(10:37) Why employers play a crucial role in addressing SUD(20:14) How harm reduction can engage people in treatment(28:49) Balancing human touch and AI in treatment approaches(32:10) What makes a recovery-ready workplace(39:44) Closing the gap with evidence-based solutions Resources:Nancy Ryerson’s LinkedIn: https://www.linkedin.com/in/nancyryerson/Dr. Suzette Glasner’s LinkedIn: https://www.linkedin.com/in/suzette-glasner-ph-d-5846804/ Pelago’s LinkedIn: https://www.linkedin.com/company/pelago-health/